Improve quality of life and control of asthma with high dose Pulmicort(r) and Oxis(r)
IMPROVE QUALITY OF LIFE AND CONTROL OF ASTHMA WITH HIGH DOSE PULMICORT(r) AND OXIS(r) New FACET data highlights additional benefits of two leading AstraZeneca compounds Lund, Sweden, December 9 /PRNEWSWIRE/ - Using inhaled Oxis(r) (formoterol), a fast-acting and long-lasting bronchodilator, together with the inhaled corticosteroid Pulmicort(r) (budesonide), both delivered via Turbuhaler(r), provides a significant and sustained improvement in health-related quality of life (HRQoL), in addition to better clinical efficacy. These were the key findings from the FACET quality of life study,